My question is; how does this differentiate from Inovio's dmAb technology?
Other than il-12, how do the intend to compete with Inovio's IP?
All the best, John
Disclaimer: Every post, and all my views are only speculative. Do not invest money or any other resources based on these post or opinions. Best of luck and do your own due diligence!